134 related articles for article (PubMed ID: 4074823)
1. Confidence limits for probability of response in multistage phase II clinical trials.
Atkinson EN; Brown BW
Biometrics; 1985 Sep; 41(3):741-4. PubMed ID: 4074823
[TBL] [Abstract][Full Text] [Related]
2. Practical side of multistage clinical trials for screening new agents.
Herson J
Cancer Treat Rep; 1983 Jan; 67(1):71-5. PubMed ID: 6616494
[TBL] [Abstract][Full Text] [Related]
3. On the estimation of the binomial probability in multistage clinical trials.
Jung SH; Kim KM
Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
[TBL] [Abstract][Full Text] [Related]
4. Design and analysis of phase I clinical trials.
Storer BE
Biometrics; 1989 Sep; 45(3):925-37. PubMed ID: 2790129
[TBL] [Abstract][Full Text] [Related]
5. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
6. Designs for group sequential phase II clinical trials.
Chang MN; Therneau TM; Wieand HS; Cha SS
Biometrics; 1987 Dec; 43(4):865-74. PubMed ID: 3427171
[TBL] [Abstract][Full Text] [Related]
7. Predictive probability early termination plans for phase II clinical trials.
Herson J
Biometrics; 1979 Dec; 35(4):775-83. PubMed ID: 526523
[TBL] [Abstract][Full Text] [Related]
8. A bayesian approach to the design of phase II clinical trials.
Sylvester RJ
Biometrics; 1988 Sep; 44(3):823-36. PubMed ID: 3203131
[TBL] [Abstract][Full Text] [Related]
9. Update on planning of phase II clinical trials.
Gehan EA
Drugs Exp Clin Res; 1986; 12(1-3):43-50. PubMed ID: 3732054
[TBL] [Abstract][Full Text] [Related]
10. Stochastically curtailed phase II clinical trials.
Ayanlowo AO; Redden DT
Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
[TBL] [Abstract][Full Text] [Related]
11. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
Shao Y; Mukhi V; Goldberg JD
Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II trials with a prospective control.
Jung SH
Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688
[TBL] [Abstract][Full Text] [Related]
13. Improving the design of phase II trials of cytostatic anticancer agents.
Stone A; Wheeler C; Barge A
Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736
[TBL] [Abstract][Full Text] [Related]
14. One- and two-stage designs for stratified phase II clinical trials.
London WB; Chang MN
Stat Med; 2005 Sep; 24(17):2597-611. PubMed ID: 16118809
[TBL] [Abstract][Full Text] [Related]
15. An adjustment for patient heterogeneity in the design of two-stage phase II trials.
Sposto R; Gaynon PS
Stat Med; 2009 Sep; 28(20):2566-79. PubMed ID: 19521973
[TBL] [Abstract][Full Text] [Related]
16. Continuous and group sequential conditional probability ratio tests for phase II clinical trials.
Tan M; Xiong X
Stat Med; 1996 Oct; 15(19):2037-51. PubMed ID: 8896138
[TBL] [Abstract][Full Text] [Related]
17. One-sample multiple testing procedure for phase II clinical trials.
Fleming TR
Biometrics; 1982 Mar; 38(1):143-51. PubMed ID: 7082756
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian predictive two-stage design for phase II clinical trials.
Sambucini V
Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
[TBL] [Abstract][Full Text] [Related]
19. An improved method of evaluating drug effect in a multiple dose clinical trial.
Shen L
Stat Med; 2001 Jul; 20(13):1913-29. PubMed ID: 11427949
[TBL] [Abstract][Full Text] [Related]
20. Adaptive designs based on the truncated product method.
Neuhäuser M; Bretz F
BMC Med Res Methodol; 2005 Sep; 5():30. PubMed ID: 16171518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
